Inspiration Biopharmaceuticals names John Butler as ceo

Replaces Michael Griffith who takes position of cso

Inspiration Biopharmaceuticals, a US biopharmaceutical company focused on the development of treatments haemophilia, has appointed John Butler as ceo. He has replaced Michael Griffith, who has become chief scientific officer and remains company president.

Butler has joined Inspiration from Genzyme, which was acquired by Sanofi in April. While at Genzyme, he was most recently president of the company's rare genetic diseases business. He also led the company's renal, endocrinology, and cardiovascular businesses.

Prior to Genzyme, Butler held sales and marketing positions at Amgen and Hoffmann-La Roche.

You may also like

Manufacturing

CMC Biologics and Inspiration agree supply of IB1001

For the treatment and prevention of bleeding in haemophilia B patients
Manufacturing

WLS introduces PR-12 and PR-24 plunger rod insertion and labelling systems

By improving reliability and streamlining production, the PR-12 and PR-24 help pharmaceutical manufacturers and contract packers protect product quality and reduce waste while maximising operational efficiencies
Pharmaceutical

Azelis strengthens its footprint in Italy with the acquisition of Azienda Chimica e Farmaceutica (‘ACEF’)

Azelis is pleased to announce that it has acquired 100% of the shares of Azienda Chimica e Farmaceutica (‘ACEF’), a distributor of speciality raw materials and ingredients for the cosmetic, nutraceutical, galenic and pharma industries in Italy
Manufacturing

Mettler-Toledo to present solutions designed to Inspect. Protect. Comply. at PPMA Total Show 2025

Mettler-Toledo to demonstrate its proven product inspection solutions designed to boost brand, productivity and profits while complying easily with industry requirements
Manufacturing

Atlas Copco expands oil-free compressor range to support critical pharmaceutical air quality standards

Atlas Copco has expanded its oil-free compressor portfolio with cutting-edge models engineered to exceed pharmaceutical air quality standards and improve energy efficiency across critical manufacturing environments
Design & Build

Roxtec launches airtight cable and pipe seal for cleanrooms, labs, and advanced facilities

Roxtec has developed the LabSeal, a new airtight and fire-rated cable and pipe penetration seal designed for cleanrooms and laboratories in the pharma, biopharma, and biotech industries
Drug Delivery

Neurizon develops oral liquid form of investigational ALS therapy, NUZ-001

The liquid format hopes to improve patient adherence, as well as the administration experience for those with ALS
Subscribe now